PROPANC BIOPHARMA, INC. OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax
PROPANC BIOPHARMA, INC. (PPCB) reported OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax of -$47.91 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax · last filed 2014-05-20
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for the quarter ending 2014-03-31 was -$47.91K.
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for the quarter ending 2013-12-31 was $56.10K.
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for the quarter ending 2013-09-30 was -$40.93K.
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for the quarter ending 2013-06-30 was $127.01K.
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for fiscal 2013 was $114.33K.
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for fiscal 2012 was -$238.73K.
- PROPANC BIOPHARMA, INC. oci, foreign currency transaction and translation gain (loss), arising during period, tax for fiscal 2011 was -$19.60K.
| Period end | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 3 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 6 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 9 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 12 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 51 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 54 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 57 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 60 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 63 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 66 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 68 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 72 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 75 month | OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax 77 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | -$47.91K 10-Q · filed 2014-05-20 | $8.19K derived: sum of 2 quarters · filed 2014-05-20 | -$32.74K 10-Q · filed 2014-05-20 | $94.27K derived: sum of 4 quarters · filed 2014-05-20 | -$277.33K 10-Q · filed 2014-05-20 | |||||||||
| 2013-12-31 | $56.10K 10-Q · filed 2014-02-14 | $15.17K 10-Q · filed 2014-02-14 | $142.18K derived: sum of 3 quarters · filed 2014-02-14 | $139.61K derived: sum of 4 quarters · filed 2014-05-20 | -$229.42K 10-Q · filed 2014-02-14 | |||||||||
| 2013-09-30 | -$40.93K 10-Q · filed 2013-11-14 | $86.08K derived: sum of 2 quarters · filed 2013-11-14 | $83.51K derived: sum of 3 quarters · filed 2014-05-20 | $83.32K derived: sum of 4 quarters · filed 2014-05-20 | -$285.52K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $127.01K derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15 | $124.44K derived: sum of 2 quarters · filed 2014-05-20 | $124.25K derived: sum of 3 quarters · filed 2014-05-20 | $114.33K 10-K · filed 2013-10-15 | -$244.59K 10-K · filed 2013-10-15 | |||||||||
| 2013-03-31 | -$2.57K 10-Q · filed 2014-05-20 | -$2.76K derived: sum of 2 quarters · filed 2014-05-20 | -$12.68K 10-Q · filed 2014-05-20 | -$64.60K derived: sum of 4 quarters · filed 2014-05-20 | -$371.60K 10-Q · filed 2013-05-20 | |||||||||
| 2012-12-31 | -$193.00 10-Q · filed 2014-02-14 | -$10.11K 10-Q · filed 2014-02-14 | -$62.03K derived: sum of 3 quarters · filed 2014-02-14 | $85.72K derived: sum of 4 quarters · filed 2014-02-14 | -$369.03K 10-Q · filed 2013-02-20 | |||||||||
| 2012-09-30 | -$9.92K 10-Q · filed 2013-11-14 | -$61.84K derived: sum of 2 quarters · filed 2013-11-14 | $85.92K derived: sum of 3 quarters · filed 2013-11-14 | $338.37K derived: sum of 4 quarters · filed 2013-11-14 | -$368.84K 10-Q · filed 2012-11-19 | |||||||||
| 2012-06-30 | -$51.92K derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-15 | $95.84K derived: sum of 2 quarters · filed 2013-10-15 | $348.29K derived: sum of 3 quarters · filed 2013-10-15 | -$238.73K 10-K · filed 2013-10-15 | -$358.92K 10-K · filed 2012-10-15 | |||||||||
| 2012-03-31 | $147.76K 10-Q · filed 2013-05-20 | $400.21K derived: sum of 2 quarters · filed 2013-05-20 | -$186.81K 10-Q · filed 2013-05-20 | -$275.83K derived: sum of 4 quarters · filed 2013-05-20 | -$307.00K 10-Q · filed 2012-05-21 | |||||||||
| 2011-12-31 | $252.46K 10-Q · filed 2013-02-20 | -$334.57K 10-Q · filed 2013-02-20 | -$423.59K derived: sum of 3 quarters · filed 2013-02-20 | -$429.64K derived: sum of 4 quarters · filed 2013-02-20 | -$454.75K 10-Q/A · filed 2012-03-07 | |||||||||
| 2011-09-30 | -$587.03K 10-Q · filed 2012-11-19 | -$676.05K derived: sum of 2 quarters · filed 2012-11-19 | -$682.10K derived: sum of 3 quarters · filed 2012-11-19 | -$658.84K derived: sum of 4 quarters · filed 2012-11-19 | ||||||||||
| 2011-06-30 | -$89.02K derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15 | -$95.07K derived: sum of 2 quarters · filed 2012-10-15 | -$71.81K derived: sum of 3 quarters · filed 2012-10-15 | -$19.60K 10-K · filed 2012-10-15 | ||||||||||
| 2011-03-31 | -$6.05K 10-Q · filed 2012-05-21 | $17.21K derived: sum of 2 quarters · filed 2012-05-21 | $69.42K 10-Q · filed 2012-05-21 | |||||||||||
| 2010-12-31 | $23.26K 10-Q/A · filed 2012-03-07 | $28.66K 10-Q/A · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |